News
2003 Press Releases
September 17, 2003
Advaxis and GlaxoSmithKline Biologicals SA Execute License Agreement for Listeriolysin O Protein Technology (LLO)
August 4, 2003
Cobra Biomanufacturing signs long-term supply agreement to manufacture active ingredient for Advaxis' novel cancer treatment